This evokes the progressive establishment of a process of self-amplification in which the increase in ACE1 makes it possible to accumulate more Ang II, and the absence of hydrolysis of this compound by ACE2 makes it possible to maintain high levels of Ang II in the plasma of COVID-19 patients. This evidence concerns the gene ACE2 and COVID-19.